Literature DB >> 8129436

Acyclovir resistant varicella zoster and HIV infection.

E G Lyall1, M M Ogilvie, N M Smith, S Burns.   

Abstract

A child infected with HIV who developed chronic varicella zoster virus infection resistant to acyclovir is presented. The clinical course of the infection, treatment, virological investigations, and relationship of the infection to the child's immunodeficient state are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8129436      PMCID: PMC1029717          DOI: 10.1136/adc.70.2.133

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

1.  Varicella in children with cancer: impact of antiviral therapy and prophylaxis.

Authors:  S Feldman; L Lott
Journal:  Pediatrics       Date:  1987-10       Impact factor: 7.124

2.  Prolonged cutaneous herpes zoster in acquired immunodeficiency syndrome.

Authors:  W B Hoppenjans; M R Bibler; R L Orme; A M Solinger
Journal:  Arch Dermatol       Date:  1990-08

3.  Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).

Authors:  M A Jacobson; T G Berger; S Fikrig; P Becherer; J W Moohr; S C Stanat; K K Biron
Journal:  Ann Intern Med       Date:  1990-02-01       Impact factor: 25.391

4.  Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS.

Authors:  S Pahwa; K Biron; W Lim; P Swenson; M H Kaplan; N Sadick; R Pahwa
Journal:  JAMA       Date:  1988-11-18       Impact factor: 56.272

Review 5.  Chronic varicella zoster in a child infected with human immunodeficiency virus: case report and review of the literature.

Authors:  E Leibovitz; A Kaul; M Rigaud; D Bebenroth; K Krasinski; W Borkowsky
Journal:  Cutis       Date:  1992-01

6.  Prolonged herpes-zoster infection associated with immunosuppressive therapy.

Authors:  J G Gallagher; T C Merigan
Journal:  Ann Intern Med       Date:  1979-12       Impact factor: 25.391

  6 in total
  9 in total

1.  Varicella zoster infection in HIV-infected children.

Authors:  C Rongkavilit; C D Mitchell; S Nachman
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

Review 2.  Role of cell culture for virus detection in the age of technology.

Authors:  Diane S Leland; Christine C Ginocchio
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.

Authors:  F Morfin; D Thouvenot; M De Turenne-Tessier; B Lina; M Aymard; T Ooka
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 4.  The use of antiviral drugs during the neonatal period.

Authors:  Richard J Whitley
Journal:  Clin Perinatol       Date:  2012-01-21       Impact factor: 3.430

5.  Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.

Authors:  Hikaru Fujii; Shizuko Harada; Tomoki Yoshikawa; Souichi Yamada; Natsumi Omura; Miho Shibamura; Takuya Inagaki; Hirofumi Kato; Shuetsu Fukushi; Masayuki Saijo
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 6.  Virological and Immunological Outcomes of Coinfections.

Authors:  Naveen Kumar; Shalini Sharma; Sanjay Barua; Bhupendra N Tripathi; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2018-07-05       Impact factor: 26.132

7.  Disseminated herpes zoster with increased CD4 counts in 3 HIV-infected patients.

Authors:  Pooja Lidhoo; Patrick Unemori; Kieron S Leslie; Toby Maurer
Journal:  J Am Acad Dermatol       Date:  2009-08       Impact factor: 11.527

8.  Antiviral Activities of Quercetin and Isoquercitrin Against Human Herpesviruses.

Authors:  Chae Hyun Kim; Jung-Eun Kim; Yoon-Jae Song
Journal:  Molecules       Date:  2020-05-20       Impact factor: 4.411

Review 9.  What clinicians need to know about antiviral drugs and viral resistance.

Authors:  R L Hodinka
Journal:  Infect Dis Clin North Am       Date:  1997-12       Impact factor: 5.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.